$LRCX

Fernandes Neil J sold $2.4M of LRCX

Fernandes Neil J (Senior Vice President) sold 7,659 shares of LAM RESEARCH CORP (LRCX) at $309.60 ($2.37M total) on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Fernandes Neil J
Published Jun 2, 2026, 4:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 4:14 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$LRCX
Neutral
medium confidence
Mentioned
$LRCX
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LRCXNeutralLow
01

Why it matters

The disclosure provides a datapoint on insider liquidity/portfolio management but does not, by itself, change fundamentals or forward expectations.

02

Market read

Expect limited incremental impact; any trading reaction is likely sentiment-driven and short duration.

03

What to watch

Traders may overweight Form 4s; the plan’s pre-arranged nature and modest share count relative to float reduce predictive value.

Relevance 4/10Novelty 3/10Timing: Filed 2026-06-02; sale executed 2026-06-01.

Background

This is an SEC Form 4 insider transaction disclosure (officer/direct holdings) for LAM Research Corp.

Company-level read

Ticker impact

$LRCXNeutralMedium confidence
Context

LRCX SVP Fernandes Neil J sold 7,659 shares in an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move solely from this Form 4; any effect would be short-lived.

Evidence & confidence

The filing is a routine officer sale under a 10b5-1 plan, with no accompanying fundamental catalyst or guidance change reported.

Market effects

Minimal; this is company-specific insider activity with no stated sector-wide shock.

None indicated.

None indicated.

Counterpoint

A 10b5-1 sale can still coincide with internal rebalancing needs; absence of buying may be less informative than the broader tape.

Key entities

  • LAM Research Corp

    Subject of the Form 4 insider sale by an officer under a 10b5-1 plan.

  • Fernandes Neil J

    Senior Vice President who sold 7,659 shares on 2026-06-01.

Related articles

$LRCXMedAI 8/10

Lam Research (LRCX) Q4 2026 Earnings Call Transcript

Lam Research’s Q4 2026 earnings call transcript says it guided $8.1 billion for the September quarter, implying over 20% quarter-on-quarter growth, and expects 2026 to be its third straight year of outperformance versus WFE. Management cited AI-driven demand across NAND, DRAM, foundry and advanced packaging, plus expanding installed-base tools like Akara, VECTOR, Argos and panel systems.

$LRCXMed

Lam Research Stock Is Gaining Friday: What's Going On?

Lam Research (LRCX) shares rose about 1% on Friday as technology stocks and semiconductor equipment peers gained. The move followed the company’s fiscal Q4 results on July 29, with revenue of $6.72B vs $6.67B expected and adjusted EPS of $1.82 vs $1.68. Lam forecast fiscal Q1 revenue of $7.70B to $8.50B and adjusted EPS of $2.00 to $2.30.

$PLTRMedAI 8/10

Dow and S&P 500 Hit Record Highs as Palantir Soars 20%, Caterpillar Jumps 10% on Earnings Beat; Oil Plunges 5% on US

US stocks extended gains to three sessions, with the Dow and S&P 500 hitting record highs. Palantir (PLTR) rose about 20% after Q2 results: revenue $1.94B (+93% YoY) and adjusted EPS $0.41 vs $0.35; full-year 2026 revenue outlook raised to $8.150B-$8.158B. Caterpillar (CAT) jumped about 10.5% on Q2 beat and $20.54B revenue. Oil fell ~5% on US-Iran deal hopes.

$MSFTHighAI 8/10

Stocks Rally on Stellar Microsoft Earnings and Chip Stock Strength

US stocks rose as investors digested strong Q2 earnings expectations and results, led by Microsoft. The article cites Bloomberg Intelligence forecasts for Q2 earnings up about 23% and notes 86% of 243 S&P 500 firms beat estimates. It also reports chip and AI-infrastructure gains tied to Lam Research and other semis, while some software names fell.